Yuhan Corporation
000100
Helyezés a részvények között
#3833
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Részvényárfolyam
$63.22
Piaci kapitalizáció
$4.27B
Változás (1 nap)
-3.12%
Változás (1 év)
-23.57%
Ország
KR
Kereskedés Yuhan Corporation (000100)
Kategória
Healthcare
EPS Yuhan Corporation (000100) részvényre
EPS June 2026 dátummal, TTM: $2.15
Yuhan Corporation legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi EPS mutatója (TTM) $2.15. 2024 végén a vállalat EPS mutatója $0.64 volt, csökkenés a 2023 év EPS értékéhez, amely $1.40 volt.
Yuhan Corporation EPS története 2007 és 2026 között
EPS minden év végén
| Év | EPS | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $2.15 | 19.67% |
| 2025 | $1.80 | 180.50% |
| 2024 | $0.64 | -54.28% |
| 2023 | $1.40 | 46.71% |
| 2022 | $0.96 | -16.23% |
| 2021 | $1.14 | -51.31% |
| 2020 | $2.34 | 388.80% |
| 2019 | $0.48 | -35.81% |
| 2018 | $0.75 | -50.07% |
| 2017 | $1.50 | -23.02% |
| 2016 | $1.94 | 31.02% |
| 2015 | $1.48 | 29.97% |
| 2014 | $1.14 | 2.35% |
| 2013 | $1.12 | 8.26% |
| 2012 | $1.03 | -3.46% |
| 2011 | $1.07 | -27.24% |
| 2010 | $1.47 | 10.23% |
| 2009 | $1.33 | 5.12% |
| 2008 | $1.27 | 1.26% |
| 2007 | $1.25 | 0.00% |
EPS hasonló cégek vagy versenytársak esetén
| Vállalat | EPS | EPS különbség | Ország |
|---|---|---|---|
| $6.55 | 203.94% |
DE
|
|
| $6.12 | 184.13% |
DE
|
|
| $0.72 | -66.43% |
JP
|
|
| $3.66 | 69.91% |
CH
|
|
| $0.53 | -75.22% |
IN
|
